STARHEALTH

Star Health & Allied Insurance This change is primarily attributed to a shift in the company's valuation grade from expensive to fair. The current price of Star Health shares stands at 455.50, down from a previous close of 463.05. Over the past year, the stock has experienced a decline of 12.10%, underperforming the BSE 500 index consistently for three years. Key financial metrics reveal a price-to-earnings (PE) ratio of 41.46 and a price-to-book value of 3.98. The company's return on equity (ROE) is reported at 9.59%, while its return on capital employed (ROCE) stands at 16.62%. Despite a strong long-term fundamental strength indicated by a 26.73% compound annual growth rate in operating profits, the company reported a significant drop in profit after tax for Q4 FY24-25, falling by 99.7% compared to the previous quarter's average. Star Health's stock performance has been marked by a 52-week high of 647.65 and a low of 330.05, reflecting volatility in its market position.